Stay updated on Dupilumab Efficacy in Persistent Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in Persistent Asthma Clinical Trial page.

Latest updates to the Dupilumab Efficacy in Persistent Asthma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedFooter now displays Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 notices were removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedPublications section now notes entries are automatically filled from PubMed and may not relate to the study, and the Revision label has been updated to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the government funding and operating status disclaimer from the page.SummaryDifference0.2%

- Check63 days agoChange DetectedThe new screenshot shows the same Study Details page with no changes to core content (e.g., study title, objectives, outcomes, eligibility, locations); only minor formatting differences are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check91 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check99 days agoChange DetectedAdded a new revision label v3.1.0 and removed several drug-safety and pharmaceutical topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision v3.0.2. The update shifts the page toward a release/versioning focus while narrowing drug-related content.SummaryDifference0.4%

Stay in the know with updates to Dupilumab Efficacy in Persistent Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in Persistent Asthma Clinical Trial page.